Literature DB >> 9736547

Association of a thr-371 substitution in a conserved amino acid motif of penicillin-binding protein 1A with penicillin resistance of Streptococcus pneumoniae.

Y Asahi1, K Ubukata.   

Abstract

We determined the nucleotide sequence between 1,903 and 3,097 bp of pbp1a, which encodes the transpeptidase domain of PBP 1A, from clinical isolates of penicillin-resistant Streptococcus pneumoniae (PRSP) serotypes 19 (n = 8), 6 (n = 9), 23 (n = 6), and 14 (n = 2) and two penicillin-susceptible S. pneumoniae (PSSP) isolates. These serotyped PRSP strains were isolated predominantly in Japan from 1993 through 1997. The 25 resistant strains were classified into five groups on the basis of the extent of sequence differences. Strains in groups I (n = 5; serotype 6), II (n = 3; serotype 19), and III (n = 12; different serotypes) had sequences highly homologous to the sequence of pbp1a of PRSP strains from South Africa, Spain, and the United States. The group IV strain (n = 1; serotype 14) had unique deletions from or insertions in the sequences. The sequences of group V strains (n = 4; serotypes 6 and 23) had relatively few differences from the sequences of the PSSP strains. For strains (n = 18) for which the threonine at codon 371 (Thr-371) in a conserved STMK motif of PBP 1A was substituted with an alanine or a serine (in addition to having altered pbp2x and pbp2b genes), penicillin MICs were >/= 1.0 microgram/ml. The PBPs 1A of these strains showed decreased affinities for [3H]benzylpenicillin and slightly faster mobilities on sodium dodecyl sulfate-polyacrylamide gels. In contrast, for strains (n = 4) without a substitution at Thr-371 in PBP 1A but with mutations in both pbp2x and pbp2b, penicillin MICs were 0.125 to 0.25 microgram/ml, and the affinities of their PBPs 1A were similar to that of PSSP PBPs 1A. Furthermore, for the Thr-371-substituted strains (n = 3) with altered pbp2x genes but native pbp2b genes, penicillin MICs were 0.125 to 0.25 microgram/ml. These results suggest that amino acid substitution of Thr-371 contributes to the development of penicillin resistance in PRSP strains with altered pbp2x and pbp2b genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736547      PMCID: PMC105808     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae.

Authors:  R Muñoz; C G Dowson; M Daniels; T J Coffey; C Martin; R Hakenbeck; B G Spratt
Journal:  Mol Microbiol       Date:  1992-09       Impact factor: 3.501

2.  Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR.

Authors:  K Ubukata; Y Asahi; A Yamane; M Konno
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F.

Authors:  T J Coffey; S Berrón; M Daniels; M E Garcia-Leoni; E Cercenado; E Bouza; A Fenoll; B G Spratt
Journal:  Microbiology       Date:  1996-10       Impact factor: 2.777

4.  Directly repeated insertion of 9-nucleotide sequence detected in penicillin-binding protein 2B gene of penicillin-resistant Streptococcus pneumoniae.

Authors:  A Yamane; H Nakano; Y Asahi; K Ubukata; M Konno
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

5.  Genetics of high level penicillin resistance in clinical isolates of Streptococcus pneumoniae.

Authors:  V A Barcus; K Ghanekar; M Yeo; T J Coffey; C G Dowson
Journal:  FEMS Microbiol Lett       Date:  1995-03-01       Impact factor: 2.742

6.  Alterations in penicillin-binding protein 2B from penicillin-resistant wild-type strains of Streptococcus pneumoniae.

Authors:  A M Smith; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

7.  Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics.

Authors:  T Grebe; R Hakenbeck
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

8.  Deletion analysis of the essentiality of penicillin-binding proteins 1A, 2B and 2X of Streptococcus pneumoniae.

Authors:  C M Kell; U K Sharma; C G Dowson; C Town; T S Balganesh; B G Spratt
Journal:  FEMS Microbiol Lett       Date:  1993-01-15       Impact factor: 2.742

9.  Mosaic pbpX genes of major clones of penicillin-resistant Streptococcus pneumoniae have evolved from pbpX genes of a penicillin-sensitive Streptococcus oralis.

Authors:  C Sibold; J Henrichsen; A König; C Martin; L Chalkley; R Hakenbeck
Journal:  Mol Microbiol       Date:  1994-06       Impact factor: 3.501

10.  Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins.

Authors:  T J Coffey; M Daniels; L K McDougal; C G Dowson; F C Tenover; B G Spratt
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

View more
  17 in total

1.  Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X in cephalosporin-resistant Streptococcus pneumoniae isolates.

Authors:  Y Asahi; Y Takeuchi; K Ubukata
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae.

Authors:  K Ubukata; Y Shibasaki; K Yamamoto; N Chiba; K Hasegawa; Y Takeuchi; K Sunakawa; M Inoue; M Konno
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Activities of ceftobiprole and other beta-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x.

Authors:  Todd A Davies; Wenchi Shang; Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

4.  Application of pbp1A PCR in identification of penicillin-resistant Streptococcus pneumoniae.

Authors:  M du Plessis; A M Smith; K P Klugman
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

5.  Penicillin-binding protein 1A, 2B, and 2X alterations in Canadian isolates of penicillin-resistant Streptococcus pneumoniae.

Authors:  Kimberly A Nichol; George G Zhanel; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

6.  Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.

Authors:  Klaudia Kosowska-Shick; Pamela McGhee; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2009-02-23       Impact factor: 5.191

7.  Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae.

Authors:  Todd A Davies; Malcolm G P Page; Wenchi Shang; Ted Andrew; Malgosia Kania; Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

8.  Alterations of penicillin-binding proteins 1A, 2X, and 2B in Streptococcus pneumoniae isolates for which amoxicillin MICs are higher than penicillin MICs.

Authors:  K Kosowska; M R Jacobs; S Bajaksouzian; L Koeth; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  Trends in antimicrobial-drug resistance in Japan.

Authors:  Y Arakawa; Y Ike; M Nagasawa; N Shibata; Y Doi; K Shibayama; T Yagi; T Kurata
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883

10.  Rapidly increasing prevalence of beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis.

Authors:  Keiko Hasegawa; Naoko Chiba; Reiko Kobayashi; Somay Y Murayama; Satoshi Iwata; Keisuke Sunakawa; Kimiko Ubukata
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.